Revance Therapeutics

-$0.17 (-0.57%) As of 5:47 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RVNC and other ETFs, options, and stocks.

About RVNC

Revance Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic applications. The firm focuses on production of daxibotulinumtoxinA, a botulinum toxin, for aesthetic and therapeutic indications including facial wrinkles and muscle movement disorders.

CEO

Mark J. Foley

Employees

470

Headquarters

Nashville, Tennessee

Founded

1999

RVNC Key Statistics

Market Cap

2.13B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

386.95K

High Today

$30.01

Low Today

$29.33

Open Price

$30.00

Volume

166.00K

52 Week High

$34.62

52 Week Low

$22.82

Analyst Ratings

100%

of 10 ratings

Buy

100%

Hold

Sell

RVNC Earnings

-$1.34

-$0.89

-$0.45

$0.00

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Expected Aug 5, After Hours